Stay updated with breaking news from Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Initial data from Phase 1 combination with capecitabine in advanced ovarian cancer are expected in mid-2023 Dose for the Phase 1 combination trials identified as 400mg daily Ended 2022 with... | March 23, 2023
CAMBRIDGE, Mass., March 21, 2023 -- Intellia Therapeutics, Inc. , a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based... | March 21, 2023
● Type D Meeting Requested to Accelerate XRx-008 Clinical Program ● CALGARY, Alberta, March 14, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc....
- Achieved more than half of enrollment in U.S. SAVVE pivotal trial of VenoValve® in 2022- Multiple near-term milestones expected across VenoValve® and enVVe clinical programs- Ended the year with $39.1
Anti-Human trafficking experts said Florida is getting "some things right" in the fight against child/youth sex trafficking, but there is room for improvement.